| 1 | Energy | XLE | +50.0% |
| 2 | Technology | XLK | +31.5% |
| 3 | Healthcare | XLV | +16.6% |
| 4 | Consumer Staples | XLP | +12.0% |
| 5 | Materials | XLB | +11.5% |
| 6 | Industrials | XLI | +6.0% |
| 7 | Real Estate | XLRE | +3.9% |
| 8 | Financials | XLF | +2.0% |
| 9 | Utilities | XLU | -0.9% |
| 10 | Consumer Disc. | XLY | -2.9% |
| 11 | Communication | XLC | -12.0% |
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. …
| Qtr | Date | EPS Est | Act | Δ | YoY | Rev Est | Act | Δ | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Q3 '26 | 10/28/26 | $-1.05 | — | — | — | — | — | — | — |
| Q2 '26 | 7/29/26 | $-1.21 | $-1.10 | +9.1% | -90% | — | $0.0B | — | — |
| Q1 '26 | 4/29/26 | $-0.92 | $-1.37 | -48.9% | -234% | — | $0.0B | — | — |
| Q4 '25 | 2/11/26 | $-0.90 | $-1.38 | -53.3% | -331% | $0.0B | $0.0B | -100.0% | — |
| Q3 '25 | 10/22/25 | $-0.68 | $-0.81 | -19.1% | -268% | — | $0.0B | — | — |
| Q2 '25 | 7/23/25 | $-0.44 | $-0.58 | -31.8% | -190% | — | $0.0B | — | — |
| Q1 '25 | 4/23/25 | $-0.31 | $-0.41 | -32.3% | -58% | — | $0.0B | — | — |